Scientists have slowed the progression of Huntington’s disease for the first time with a “groundbreaking” new treatment.
In an update from uniQure, they report that their experimental gene therapy, AMT-130, has the potential to slow Huntington’s ...
PsyPost on MSN
Scientists discover a key mechanism for dopamine to regulate brain activity and movement
A new study published in Brain Sciences provides evidence that dopamine promotes movement by directly altering the excitability of key neurons in the brain’s motor circuitry. The research identifies a ...
Scientists have slowed the progression of Huntington’s disease for the first time with a “groundbreaking” new treatment.
A global clinical trial for a new Huntington's disease treatment has posted positive results today, announced by trial sponsor uniQure and UCL ...
After 36 months, patients treated with high dose AMT-130 saw a 75% slowing of disease progression vs the external control.
Discover Alector's latest breakthroughs in neurodegenerative disease therapies, including updates on Alzheimer's and Parkinson's programs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback